Recessively‐Inherited Adult‐Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene
Background Alexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene. Objectives The objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult‐on...
Saved in:
Published in | Movement disorders Vol. 35; no. 9; pp. 1662 - 1667 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.09.2020
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
ISSN | 0885-3185 1531-8257 1531-8257 |
DOI | 10.1002/mds.28099 |
Cover
Abstract | Background
Alexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene.
Objectives
The objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult‐onset AxD.
Methods
A man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality.
Results
A homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild‐type protein rescued mutational effects, consistent with the recessive nature of this mutation.
Conclusions
This study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society |
---|---|
AbstractList | BackgroundAlexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene.ObjectivesThe objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult‐onset AxD.MethodsA man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality.ResultsA homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild‐type protein rescued mutational effects, consistent with the recessive nature of this mutation.ConclusionsThis study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society Alexander disease (AxD) is an autosomal-dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene. The objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult-onset AxD. A man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality. A homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild-type protein rescued mutational effects, consistent with the recessive nature of this mutation. This study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society. Alexander disease (AxD) is an autosomal-dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene.BACKGROUNDAlexander disease (AxD) is an autosomal-dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene.The objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult-onset AxD.OBJECTIVESThe objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult-onset AxD.A man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality.METHODSA man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality.A homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild-type protein rescued mutational effects, consistent with the recessive nature of this mutation.RESULTSA homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild-type protein rescued mutational effects, consistent with the recessive nature of this mutation.This study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society.CONCLUSIONSThis study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society. Background Alexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene. Objectives The objective of this report is to characterize the clinical phenotype and identify the genetic mutation associated with adult‐onset AxD. Methods A man presented with progressive unsteadiness since age 16. Magnetic resonance imaging findings revealed characteristic features of AxD. The GFAP gene was screened, and a candidate variant was functionally tested to evaluate causality. Results A homozygous c.197G > A (p.Arg66Gln) mutation was found in the proband, and his asymptomatic parents were heterozygous for the same mutation. This mutation affected GFAP solubility and promoted filament aggregation. The presence of the wild‐type protein rescued mutational effects, consistent with the recessive nature of this mutation. Conclusions This study is the first report of AxD caused by a homozygous mutation in GFAP. The clinical implication is while examining patients with characteristic features on suspicion of AxD, GFAP screening is recommended even without a supportive family history. © 2020 International Parkinson and Movement Disorder Society |
Author | Chang, Chiung‐Chih Peng, Cheng‐Huei Lan, Min‐Yu Fu, Mu‐Hui Lin, Ni‐Hsuan Wu, Kay, L.H. Chang, Yung‐Yee Yang, Ai‐Wen Perng, Ming‐Der Liu, Jia‐Shou |
Author_xml | – sequence: 1 givenname: Mu‐Hui orcidid: 0000-0003-2895-794X surname: Fu fullname: Fu, Mu‐Hui organization: Chang Gung University College of Medicine – sequence: 2 givenname: Yung‐Yee surname: Chang fullname: Chang, Yung‐Yee organization: Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine – sequence: 3 givenname: Ni‐Hsuan surname: Lin fullname: Lin, Ni‐Hsuan organization: Institute of Molecular Medicine, College of Life Sciences, National Tsing Hua University – sequence: 4 givenname: Ai‐Wen surname: Yang fullname: Yang, Ai‐Wen organization: National Tsing Hua University – sequence: 5 givenname: Chiung‐Chih surname: Chang fullname: Chang, Chiung‐Chih organization: Chang Gung University College of Medicine – sequence: 6 givenname: Jia‐Shou surname: Liu fullname: Liu, Jia‐Shou organization: Chang Gung University College of Medicine – sequence: 7 givenname: Cheng‐Huei surname: Peng fullname: Peng, Cheng‐Huei organization: Chang Gung University College of Medicine – sequence: 8 givenname: Kay, L.H. surname: Wu fullname: Wu, Kay, L.H. organization: National Tainan Institute of Nursing – sequence: 9 givenname: Ming‐Der orcidid: 0000-0002-1884-3714 surname: Perng fullname: Perng, Ming‐Der email: mdperng@life.nthu.edu.tw organization: National Tsing Hua University – sequence: 10 givenname: Min‐Yu surname: Lan fullname: Lan, Min‐Yu organization: Kaohsiung Chang Gung Memorial Hospital, and Chang Gung University College of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32374915$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1O3DAUha0KVAbaRV8AWeoGFgP-rZ3laIABCUTVsrec-KZjlDhgJ0BY8Qg8Y5-khhk2iK6udPWdc4_u2UYboQuA0DdKDigh7LB16YBpUhSf0IRKTqeaSbWBJkRrOeVUyy20ndI1IZRK-uMz2uKMK1FQOUHLX1BBSv4OmvHv0_NZWEL0PTg8c0PT581lSNDjWQMPNjiI-MgnsAnw3A4pY-WILT7t2u5x_NMNCV8Mve19F7APuF8CXpzMfuIFBPiCNmvbJPi6njvo6uT4an46Pb9cnM1n59OKa13k5KWqa6GsdVxJAUILQhWprCUld0wRSnQhlSOi0qUmThDFaMUzUNaKcL6D9la2N7G7HSD1pvWpgqaxAXI-w3hR6HxJsox-f4ded0MMOZxhQjCpmeAyU7traihbcOYm-tbG0by9MAOHK6CKXUoRalP51Q_6aH1jKDEvJZlcknktKSv23yneTD9i1-73voHx_6C5OPq9UvwDK9Wgww |
CitedBy_id | crossref_primary_10_1177_1759091420949680 crossref_primary_10_3389_fneur_2022_1002527 crossref_primary_10_14802_jmd_22127 crossref_primary_10_1038_s41583_022_00641_1 crossref_primary_10_1186_s40001_022_00799_5 |
Cites_doi | 10.1007/s00415-012-6540-4 10.1016/0896-6273(95)90238-4 10.1016/j.parkreldis.2013.10.014 10.1086/504411 10.1016/S0896-6273(00)80194-4 10.1093/brain/awn178 10.1001/archneurol.2011.1181 10.1186/1471-2377-10-21 10.1002/j.1460-2075.1995.tb07147.x 10.1016/j.jns.2004.07.008 10.1016/j.ceb.2015.02.004 10.1242/jcs.02339 10.1038/83679 10.7554/eLife.47789 10.1042/AN20130032 10.1006/jmbi.2000.3719 10.1093/brain/72.3.373 10.1212/01.wnl.0000198770.80743.37 10.1002/ana.20406 10.1073/pnas.93.13.6361 10.1001/archneur.60.9.1307 10.1212/WNL.0b013e3182309f72 10.1212/WNL.26.7.607 10.1371/journal.pone.0180694 10.1212/WNL.58.10.1494 |
ContentType | Journal Article |
Copyright | 2020 International Parkinson and Movement Disorder Society 2020 International Parkinson and Movement Disorder Society. |
Copyright_xml | – notice: 2020 International Parkinson and Movement Disorder Society – notice: 2020 International Parkinson and Movement Disorder Society. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
DOI | 10.1002/mds.28099 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts Technology Research Database Engineering Research Database ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Nursing & Allied Health Premium Genetics Abstracts Technology Research Database ProQuest Health & Medical Complete (Alumni) Engineering Research Database Neurosciences Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitleList | Nursing & Allied Health Premium MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1531-8257 |
EndPage | 1667 |
ExternalDocumentID | 32374915 10_1002_mds_28099 MDS28099 |
Genre | shortCommunication Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Ministry of Science and Technology, Taiwan funderid: 108‐2918‐I‐007‐013; MOST‐104‐2731‐M‐007‐002 – fundername: National Tsing Hua University funderid: 107A0109V6; 108A0117V6 |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1CY 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANHP AANLZ AAONW AASGY AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACRPL ACSCC ACXBN ACXQS ACYXJ ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBD EBS EJD EMOBN F00 F01 F04 F5P FEDTE FUBAC FYBCS G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6M MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR ROL RWD RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZGI ZZTAW ~IA ~WT AAYXX AEYWJ AGHNM AGQPQ AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 7TK 8FD FR3 K9. NAPCQ P64 RC3 7X8 |
ID | FETCH-LOGICAL-c3889-82b7ff47aad3754e4840170caa0b3d270108957d04c8b80d40721c30cabf7033 |
IEDL.DBID | DR2 |
ISSN | 0885-3185 1531-8257 |
IngestDate | Thu Jul 10 23:17:49 EDT 2025 Mon Jul 14 10:43:57 EDT 2025 Mon Jul 21 05:49:17 EDT 2025 Tue Jul 01 01:44:25 EDT 2025 Thu Apr 24 23:08:20 EDT 2025 Wed Jan 22 16:32:05 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 9 |
Keywords | Alexander disease leukodystrophy astrocyte GFAP recessive mutation |
Language | English |
License | 2020 International Parkinson and Movement Disorder Society. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3889-82b7ff47aad3754e4840170caa0b3d270108957d04c8b80d40721c30cabf7033 |
Notes | Nothing to report. Relevant conflicts of interests/financial disclosures Funding agencies This work was supported by grants from the Ministry of Science and Technology (Grant 108‐2918‐I‐007‐013 to M.D.P.) and National Tsing Hua University (Grants 107A0109V6 and 108A0117V6 to M.D.P., N.S.L., and A.W.Y). ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-1884-3714 0000-0003-2895-794X |
OpenAccessLink | https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28099 |
PMID | 32374915 |
PQID | 2442582435 |
PQPubID | 1016421 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_2399838852 proquest_journals_2442582435 pubmed_primary_32374915 crossref_citationtrail_10_1002_mds_28099 crossref_primary_10_1002_mds_28099 wiley_primary_10_1002_mds_28099_MDS28099 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | September 2020 2020-09-00 20200901 |
PublicationDateYYYYMMDD | 2020-09-01 |
PublicationDate_xml | – month: 09 year: 2020 text: September 2020 |
PublicationDecade | 2020 |
PublicationPlace | Hoboken, USA |
PublicationPlace_xml | – name: Hoboken, USA – name: United States – name: Hoboken |
PublicationTitle | Movement disorders |
PublicationTitleAlternate | Mov Disord |
PublicationYear | 2020 |
Publisher | John Wiley & Sons, Inc Wiley Subscription Services, Inc |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley Subscription Services, Inc |
References | 2019; 8 2010; 10 2002; 58 1996; 17 2004; 225 2006; 79 1995; 14 2015; 32 2005; 118 2008 1996; 93 2011; 77 2001; 27 2000; 298 1949; 72 2013; 5 1976; 26 2014; 20 2006; 66 2017; 12 2003; 60 2012; 69 2012; 259 2008; 131 2005; 57 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_17_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 Brenner M (e_1_2_7_9_1) 2008 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 |
References_xml | – volume: 79 start-page: 197 issue: 2 year: 2006 end-page: 213 article-title: The Alexander disease‐causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B‐crystallin and HSP27 publication-title: Am J Hum Genet – volume: 118 start-page: 2057 issue: Pt 9 year: 2005 end-page: 2065 article-title: Alexander‐disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP publication-title: J Cell Sci – volume: 20 start-page: 241 issue: 2 year: 2014 end-page: 242 article-title: Adult onset Alexander disease presenting with progressive spastic paraplegia publication-title: Parkinsonism Relat Disord – volume: 66 start-page: 494 issue: 4 year: 2006 end-page: 498 article-title: Alexander disease: ventricular garlands and abnormalities of the medulla and spinal cord publication-title: Neurology – volume: 225 start-page: 125 issue: 1‐2 year: 2004 end-page: 127 article-title: Asymptomatic hereditary Alexander's disease caused by a novel mutation in GFAP publication-title: J Neurol Sci – volume: 27 start-page: 117 issue: 1 year: 2001 end-page: 120 article-title: Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease publication-title: Nat Genet – volume: 77 start-page: 1287 issue: 13 year: 2011 end-page: 1294 article-title: GFAP mutations, age at onset, and clinical subtypes in Alexander disease publication-title: Neurology – volume: 60 start-page: 1307 issue: 9 year: 2003 end-page: 1312 article-title: Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene publication-title: Arch Neurol – volume: 26 start-page: 607 issue: 7 year: 1976 end-page: 614 article-title: Alexander's disease: a report and reappraisal publication-title: Neurology – volume: 93 start-page: 6361 issue: 13 year: 1996 end-page: 6366 article-title: Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology publication-title: Proc Natl Acad Sci U S A – volume: 17 start-page: 607 issue: 4 year: 1996 end-page: 615 article-title: GFAP is necessary for the integrity of CNS white matter architecture and long‐term maintenance of myelination publication-title: Neuron – volume: 69 start-page: 208 issue: 2 year: 2012 end-page: 214 article-title: Archetypal and new families with Alexander disease and novel mutations in GFAP publication-title: Arch Neurol – volume: 298 start-page: 817 issue: 5 year: 2000 end-page: 832 article-title: The intermediate filament protein consensus motif of helix 2B: its atomic structure and contribution to assembly publication-title: J Mol Biol – volume: 32 start-page: 121 year: 2015 end-page: 130 article-title: Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system publication-title: Curr Opin Cell Biol – volume: 10 start-page: 21 year: 2010 article-title: Adult‐onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature publication-title: BMC Neurol – volume: 14 start-page: 1590 issue: 8 year: 1995 end-page: 1598 article-title: Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally publication-title: EMBO J – volume: 12 issue: 7 year: 2017 article-title: Characterization of a panel of monoclonal antibodies recognizing specific epitopes on GFAP publication-title: PLoS One – volume: 57 start-page: 310 issue: 3 year: 2005 end-page: 326 article-title: Glial fibrillary acidic protein mutations i infantile, juvenile, and adult forms of Alexander disease publication-title: Ann Neurol – volume: 58 start-page: 1494 issue: 10 year: 2002 end-page: 1500 article-title: Molecular findings in symptomatic and pre‐symptomatic Alexander disease patients publication-title: Neurology – volume: 131 start-page: 2321 issue: Pt 9 year: 2008 end-page: 2331 article-title: Adult‐onset Alexander disease: a series of eleven unrelated cases with review of the literature publication-title: Brain – volume: 14 start-page: 29 issue: 1 year: 1995 end-page: 41 article-title: Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions publication-title: Neuron – volume: 5 issue: 5 year: 2013 article-title: Caspase cleavage of GFAP produces an assembly‐compromised proteolytic fragment that promotes filament aggregation publication-title: ASN Neuro – start-page: 591 year: 2008 end-page: 648 – volume: 8 year: 2019 article-title: Site‐specific phosphorylation and caspase cleavage of GFAP are new markers of Alexander disease severity publication-title: Elife – volume: 259 start-page: 2234 issue: 10 year: 2012 end-page: 2236 article-title: Adult‐onset Alexander disease with an R66Q mutation in GFAP presented with severe vocal cord paralysis during sleep publication-title: J Neurol – volume: 72 start-page: 373 issue: 3 year: 1949 end-page: 381 article-title: Progressive fibrinoid degeneration of fibrillary astrocytes associated with mental retardation in a hydrocephalic infant publication-title: Brain – ident: e_1_2_7_20_1 doi: 10.1007/s00415-012-6540-4 – ident: e_1_2_7_10_1 doi: 10.1016/0896-6273(95)90238-4 – ident: e_1_2_7_21_1 doi: 10.1016/j.parkreldis.2013.10.014 – ident: e_1_2_7_17_1 doi: 10.1086/504411 – ident: e_1_2_7_11_1 doi: 10.1016/S0896-6273(00)80194-4 – ident: e_1_2_7_4_1 doi: 10.1093/brain/awn178 – ident: e_1_2_7_25_1 doi: 10.1001/archneurol.2011.1181 – ident: e_1_2_7_6_1 doi: 10.1186/1471-2377-10-21 – ident: e_1_2_7_13_1 doi: 10.1002/j.1460-2075.1995.tb07147.x – ident: e_1_2_7_22_1 doi: 10.1016/j.jns.2004.07.008 – ident: e_1_2_7_8_1 doi: 10.1016/j.ceb.2015.02.004 – ident: e_1_2_7_19_1 doi: 10.1242/jcs.02339 – ident: e_1_2_7_7_1 doi: 10.1038/83679 – ident: e_1_2_7_27_1 doi: 10.7554/eLife.47789 – ident: e_1_2_7_18_1 doi: 10.1042/AN20130032 – ident: e_1_2_7_26_1 doi: 10.1006/jmbi.2000.3719 – start-page: 591 volume-title: Astrocytes in Pathophysiology of the Nervous System year: 2008 ident: e_1_2_7_9_1 – ident: e_1_2_7_2_1 doi: 10.1093/brain/72.3.373 – ident: e_1_2_7_5_1 doi: 10.1212/01.wnl.0000198770.80743.37 – ident: e_1_2_7_15_1 doi: 10.1002/ana.20406 – ident: e_1_2_7_12_1 doi: 10.1073/pnas.93.13.6361 – ident: e_1_2_7_23_1 doi: 10.1001/archneur.60.9.1307 – ident: e_1_2_7_14_1 doi: 10.1212/WNL.0b013e3182309f72 – ident: e_1_2_7_3_1 doi: 10.1212/WNL.26.7.607 – ident: e_1_2_7_16_1 doi: 10.1371/journal.pone.0180694 – ident: e_1_2_7_24_1 doi: 10.1212/WNL.58.10.1494 |
SSID | ssj0011516 |
Score | 2.3592231 |
Snippet | Background
Alexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene.... Alexander disease (AxD) is an autosomal-dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP) gene. The... BackgroundAlexander disease (AxD) is an autosomal‐dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP)... Alexander disease (AxD) is an autosomal-dominant leukodystrophy caused by heterozygous mutations in the glial fibrillary acidic protein (GFAP)... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1662 |
SubjectTerms | Adolescent Adult Alexander disease Alexander Disease - diagnostic imaging Alexander Disease - genetics Alexander's disease astrocyte GFAP Glial fibrillary acidic protein Glial Fibrillary Acidic Protein - genetics Homozygote Humans Leukodystrophy Magnetic resonance imaging Male Movement disorders Mutation Mutation - genetics Phenotype Phenotypes recessive mutation |
Title | Recessively‐Inherited Adult‐Onset Alexander Disease Caused by a Homozygous Mutation in the GFAP Gene |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.28099 https://www.ncbi.nlm.nih.gov/pubmed/32374915 https://www.proquest.com/docview/2442582435 https://www.proquest.com/docview/2399838852 |
Volume | 35 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library - Core collection (SURFmarket) issn: 0885-3185 databaseCode: DR2 dateStart: 19990101 customDbUrl: isFulltext: true eissn: 1531-8257 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011516 providerName: Wiley-Blackwell |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB5VPVRcSgsUli6VQRx62W1iO-usOK1algVpC4Ii9VAp8l8Kos1WzQZp98Qj8Iw8Scd2EtSWSqi3KB7Lscdjf87MfAZ4LZnlNmGmp-Vg0ONU6RAEkHDNmTAizo07KE4PB5Ov_MNxcrwCb5pcmMAP0f5wc5bh12tn4FKVe39JQ89N2acpAhxcf2OWeBft55Y6CoGOv_YUjSjxGcINq1BE99qa1_eiWwDzOl71G874IZw0nxriTH70q7nq6-UNFsd79mUD1msgSkZh5mzCii0ewdq0drU_hm8IKF2I7E97tvjz6_f7wiUKIjwlI8fYgW8-FqWdkzZBhhwEVw_Zl1WJYmpBJJnMzmfLxemsKsm0Ck5_8r0gCDrJu_HoE3Gk10_gaPz2aH_Sq69l6GnmYqJSqkSecyGlcffnWo5nxFhEWspIMUMFqjodJsJEXKcqjYynYNMMBVSO6wvbgtViVthnQOTQpMbEgsWKc6NyaSPhCAspNYLxnHdgt9FPpmvKcndzxlkWyJZphgOX-YHrwKtW9CLwdPxLqNsoOatNFUs4LlspRdjYgZdtMRqZ85zIwuIQZS4BOMXOJ7QDT8PkaFthlAk-jLH2rlfx3c1n04Mv_uH5_4tuwwPqTvg-qq0Lq_PLyr5AGDRXO36-XwH8DwN2 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgGX8oYtLRjEoZfdJrazzkpcVl2WLTQFwSL1giK_AqhttupuKm1P_AR-I7-kYzsJKg8JcYuSsRx7PPZnz8xngOeSWW4TZrpa9vtdTpUOQQAJ15wJI-LCuI1itt-ffOSvD5KDFXjR5MIEfoj2wM1Zhp-vnYG7A-ntn6yhx2beoykinCtw1fnnnFmO3rfkUQh1_MWnaEaJzxFueIUiut0Wvbwa_QYxLyNWv-SMb8Kn5mdDpMlhr1qonj7_hcfxf1tzC9ZqLEqGYfDchhVb3oFrWe1tvwtfEFO6KNkze7T88e37bulyBRGhkqEj7cA3b8u5XZA2R4aMgreH7MhqjmJqSSSZzI5n58vPs2pOsir4_cnXkiDuJK_Gw3fE8V7fg-n45XRn0q1vZuhq5sKiUqpEUXAhpXFX6FqO28RYRFrKSDFDBWo7HSTCRFynKo2MZ2HTDAVUgVMMuw-r5ay0D4HIgUmNiQWLFedGFdJGwnEWUmoE4wXvwFajoFzXrOXu8oyjPPAt0xw7Lvcd14FnrehJoOr4k9BGo-W8tlb8wnHmSikixw48bT-jnTnniSwtdlHucoBTbHxCO_AgjI62FkaZ4IMYS295Hf-9-jwbffAP6_8u-gSuT6bZXr63u__mEdygbsPvg9w2YHVxWtlNREUL9dgP_gsosAeS |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RkFAvpe8u0NateuCyS2I766x6WrFdlrZLUUslDkiRX2krIIvYDdJy4ifwG_kljO0kFX1IVW9RPJZjj8f-HM98A_BGMsttwkxby263zanSwQkg4ZozYUScG3dQHO92R1_5-4PkYAHe1rEwgR-i-eHmLMOv187AT02--ZM09MRMOzRFgHMHlngXT1cOEX1uuKMQ6fi8p2hFiQ8RrmmFIrrZVL29Gf2GMG8DVr_jDFfgsP7W4Ghy1ClnqqMvfqFx_M_O3Id7FRIl_TB1HsCCLR7C8ri6a38E3xFROh_Zc3s8v7682ilcpCDiU9J3lB345lMxtTPSRMiQQbjrIVuynKKYmhNJRpOTycX826ScknEZbv3Jj4Ig6iTbw_4ecazXj2F_-G5_a9Su8jK0NXNOUSlVIs-5kNK4BLqW4yExFpGWMlLMUIG6TnuJMBHXqUoj4znYNEMBleMCw57AYjEp7DMgsmdSY2LBYsW5Ubm0kXCMhZQawXjOW7BR6yfTFWe5S51xnAW2ZZrhwGV-4FrwuhE9DUQdfxJar5WcVbaKJRzXrZQibmzBq6YYrcxdncjC4hBlLgI4xc4ntAVPw-RoWmGUCd6LsfaGV_Hfm8_Ggy_-YfXfRV_C8t5gmH3c2f2wBnepO-17D7d1WJydlfY5QqKZeuGn_g0SAgZB |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recessively%E2%80%90Inherited+Adult%E2%80%90Onset+Alexander+Disease+Caused+by+a+Homozygous+Mutation+in+the+GFAP+Gene&rft.jtitle=Movement+disorders&rft.au=Mu%E2%80%90Hui+Fu&rft.au=Yung%E2%80%90Yee+Chang&rft.au=Ni%E2%80%90Hsuan+Lin&rft.au=Ai%E2%80%90Wen+Yang&rft.date=2020-09-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0885-3185&rft.eissn=1531-8257&rft.volume=35&rft.issue=9&rft.spage=1662&rft.epage=1667&rft_id=info:doi/10.1002%2Fmds.28099&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |